Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes

Lucie M Turcotte, Tao Wang, Michael T. Hemmer, Stephen R. Spellman, Mukta Arora, Ashley Yingst, Daniel Couriel, Amin Alousi, Joseph Pidala, Jennifer M. Knight, Michael R. Verneris

Research output: Contribution to journalArticle

Abstract

Graft-versus-host disease (GVHD) is a frequent cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT). GVHD occurs when donor lymphocytes are activated by inflammatory cytokines and alloantigens. The role of donor biologic characteristics, such as basal inflammation, has not been investigated as a risk factor for GVHD but is theoretically transferrable to the recipient. We evaluated donor serum and plasma concentrations of cytokines and adipokines (IL-1β IL-6, tumor necrosis factor [TNF]-α leptin, suppression of tumorigenicity-2, and adiponectin) from test (n = 210) and replication (n = 250) cohorts of matched, unrelated transplant peripheral blood stem cell recipients identified through the Center for International Blood and Marrow Transplantation Research between 2000 and 2011 for hematologic malignancies. Hazard ratios were estimated for acute (grades II to IV and III to IV) and chronic GVHD, overall survival, disease-free survival, transplant-related mortality, and relapse for each cytokine or adipokine, adjusting for significant covariates. The lowest cytokine quartile was considered as the reference group for each model. To account for multiple testing P <.01 was considered the threshold for significance. In the test cohort a borderline significant association was identified between donor serum IL-1β concentrations and grades III to IV acute GVHD in the recipient (P =.01), and a significant inverse association was identified between donor TNF-α concentrations and chronic GVHD (P =.006). These findings were not validated in the replication cohort. Although the initial associations between cytokine levels and allo-HCT outcomes were not validated, the idea that donor characteristics may be transferable to the recipient remains an exciting area for future research.

Original languageEnglish (US)
Pages (from-to)12-18
Number of pages7
JournalBiology of Blood and Marrow Transplantation
Volume25
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Unrelated Donors
Adipokines
Cell Transplantation
Graft vs Host Disease
Bone Marrow
Cytokines
Tissue Donors
Interleukin-1
Tumor Necrosis Factor-alpha
Transplants
Isoantigens
Mortality
Adiponectin
Hematologic Neoplasms
Leptin
Serum
Disease-Free Survival
Interleukin-6
Transplantation
Lymphocytes

Keywords

  • Cytokines
  • GVHD
  • HCT donor

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

Cite this

Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes. / Turcotte, Lucie M; Wang, Tao; Hemmer, Michael T.; Spellman, Stephen R.; Arora, Mukta; Yingst, Ashley; Couriel, Daniel; Alousi, Amin; Pidala, Joseph; Knight, Jennifer M.; Verneris, Michael R.

In: Biology of Blood and Marrow Transplantation, Vol. 25, No. 1, 01.01.2019, p. 12-18.

Research output: Contribution to journalArticle

Turcotte, Lucie M ; Wang, Tao ; Hemmer, Michael T. ; Spellman, Stephen R. ; Arora, Mukta ; Yingst, Ashley ; Couriel, Daniel ; Alousi, Amin ; Pidala, Joseph ; Knight, Jennifer M. ; Verneris, Michael R. / Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes. In: Biology of Blood and Marrow Transplantation. 2019 ; Vol. 25, No. 1. pp. 12-18.
@article{4ebcf635b852474db90fd21688d46042,
title = "Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes",
abstract = "Graft-versus-host disease (GVHD) is a frequent cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT). GVHD occurs when donor lymphocytes are activated by inflammatory cytokines and alloantigens. The role of donor biologic characteristics, such as basal inflammation, has not been investigated as a risk factor for GVHD but is theoretically transferrable to the recipient. We evaluated donor serum and plasma concentrations of cytokines and adipokines (IL-1β IL-6, tumor necrosis factor [TNF]-α leptin, suppression of tumorigenicity-2, and adiponectin) from test (n = 210) and replication (n = 250) cohorts of matched, unrelated transplant peripheral blood stem cell recipients identified through the Center for International Blood and Marrow Transplantation Research between 2000 and 2011 for hematologic malignancies. Hazard ratios were estimated for acute (grades II to IV and III to IV) and chronic GVHD, overall survival, disease-free survival, transplant-related mortality, and relapse for each cytokine or adipokine, adjusting for significant covariates. The lowest cytokine quartile was considered as the reference group for each model. To account for multiple testing P <.01 was considered the threshold for significance. In the test cohort a borderline significant association was identified between donor serum IL-1β concentrations and grades III to IV acute GVHD in the recipient (P =.01), and a significant inverse association was identified between donor TNF-α concentrations and chronic GVHD (P =.006). These findings were not validated in the replication cohort. Although the initial associations between cytokine levels and allo-HCT outcomes were not validated, the idea that donor characteristics may be transferable to the recipient remains an exciting area for future research.",
keywords = "Cytokines, GVHD, HCT donor",
author = "Turcotte, {Lucie M} and Tao Wang and Hemmer, {Michael T.} and Spellman, {Stephen R.} and Mukta Arora and Ashley Yingst and Daniel Couriel and Amin Alousi and Joseph Pidala and Knight, {Jennifer M.} and Verneris, {Michael R.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.bbmt.2018.08.011",
language = "English (US)",
volume = "25",
pages = "12--18",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes

AU - Turcotte, Lucie M

AU - Wang, Tao

AU - Hemmer, Michael T.

AU - Spellman, Stephen R.

AU - Arora, Mukta

AU - Yingst, Ashley

AU - Couriel, Daniel

AU - Alousi, Amin

AU - Pidala, Joseph

AU - Knight, Jennifer M.

AU - Verneris, Michael R.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Graft-versus-host disease (GVHD) is a frequent cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT). GVHD occurs when donor lymphocytes are activated by inflammatory cytokines and alloantigens. The role of donor biologic characteristics, such as basal inflammation, has not been investigated as a risk factor for GVHD but is theoretically transferrable to the recipient. We evaluated donor serum and plasma concentrations of cytokines and adipokines (IL-1β IL-6, tumor necrosis factor [TNF]-α leptin, suppression of tumorigenicity-2, and adiponectin) from test (n = 210) and replication (n = 250) cohorts of matched, unrelated transplant peripheral blood stem cell recipients identified through the Center for International Blood and Marrow Transplantation Research between 2000 and 2011 for hematologic malignancies. Hazard ratios were estimated for acute (grades II to IV and III to IV) and chronic GVHD, overall survival, disease-free survival, transplant-related mortality, and relapse for each cytokine or adipokine, adjusting for significant covariates. The lowest cytokine quartile was considered as the reference group for each model. To account for multiple testing P <.01 was considered the threshold for significance. In the test cohort a borderline significant association was identified between donor serum IL-1β concentrations and grades III to IV acute GVHD in the recipient (P =.01), and a significant inverse association was identified between donor TNF-α concentrations and chronic GVHD (P =.006). These findings were not validated in the replication cohort. Although the initial associations between cytokine levels and allo-HCT outcomes were not validated, the idea that donor characteristics may be transferable to the recipient remains an exciting area for future research.

AB - Graft-versus-host disease (GVHD) is a frequent cause of morbidity and mortality after allogeneic hematopoietic cell transplantation (allo-HCT). GVHD occurs when donor lymphocytes are activated by inflammatory cytokines and alloantigens. The role of donor biologic characteristics, such as basal inflammation, has not been investigated as a risk factor for GVHD but is theoretically transferrable to the recipient. We evaluated donor serum and plasma concentrations of cytokines and adipokines (IL-1β IL-6, tumor necrosis factor [TNF]-α leptin, suppression of tumorigenicity-2, and adiponectin) from test (n = 210) and replication (n = 250) cohorts of matched, unrelated transplant peripheral blood stem cell recipients identified through the Center for International Blood and Marrow Transplantation Research between 2000 and 2011 for hematologic malignancies. Hazard ratios were estimated for acute (grades II to IV and III to IV) and chronic GVHD, overall survival, disease-free survival, transplant-related mortality, and relapse for each cytokine or adipokine, adjusting for significant covariates. The lowest cytokine quartile was considered as the reference group for each model. To account for multiple testing P <.01 was considered the threshold for significance. In the test cohort a borderline significant association was identified between donor serum IL-1β concentrations and grades III to IV acute GVHD in the recipient (P =.01), and a significant inverse association was identified between donor TNF-α concentrations and chronic GVHD (P =.006). These findings were not validated in the replication cohort. Although the initial associations between cytokine levels and allo-HCT outcomes were not validated, the idea that donor characteristics may be transferable to the recipient remains an exciting area for future research.

KW - Cytokines

KW - GVHD

KW - HCT donor

UR - http://www.scopus.com/inward/record.url?scp=85053858381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053858381&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2018.08.011

DO - 10.1016/j.bbmt.2018.08.011

M3 - Article

VL - 25

SP - 12

EP - 18

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 1

ER -